NCT05741658View on ClinicalTrials.gov

The Fontan Dapagliflozin Pilot Study

PHASE4Enrolling by invitationINTERVENTIONAL

Enrollment

29

Participants

Timeline

Start Date

November 8, 2023

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions

Heart Failure

Interventions

DRUG

Dapagliflozin 10mg Tab

Participants will take one Dapagliflozin 10mg tablet once per day for 4 weeks.

Trial Locations (1)

90095

Ronald Reagan UCLA Medical Center, Los Angeles

Sponsors

Collaborators (1)

All Listed Sponsors

collaborator

University of California, Los Angeles

OTHER

collaborator

Brett Boyer Foundation

UNKNOWN

collaborator

AstraZeneca

INDUSTRY

lead

Johns Hopkins University

OTHER